Clinical Trials Directory

Trials / Unknown

UnknownNCT04387058

Incidence of Diabetes and Metabolic Disorders After TIPS in Cirrhotic Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
111 (estimated)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Decompensated cirrhosis is associated with sarcopenia. TIPS is an efficient treatment of portal hypertension. Based on our retrospective data, TIPS induces in 30% of cirrhotic patients metabolic disorders associated with diabetes or pre-diabetes. The main objective is to measure the cumulative incidence of diabetes and pre-diabetes 6 months after TIPS insertion.

Detailed description

Based on our retrospective data, we expect that one-third of cirrhotic patients develop glucose dysregulation after TIPS. A better knowledge of the metabolic disorders related to the TIPS could allow to prevent the deleterious effects of the TIPS on the disease (decrease of the insulin-sensitivity, fat gain ...), by simple interventions on diet or physical activity. We will assess the incidence of diabetes and pre-diabetes, and the influence of TIPS on nutritional status and sarcopenia. Patients will be follow-up 6 months after TIPS. We will explore the hormonal mechanisms that explain these changes.

Conditions

Interventions

TypeNameDescription
DEVICETIPSTIPS (Transjugular Intrahepatic Portosystemic Shunt) is an interventional radiology method that creates an anastomosis between the portal venous network and the hepatic venous network.

Timeline

Start date
2019-06-16
Primary completion
2022-06-16
Completion
2022-06-16
First posted
2020-05-13
Last updated
2020-05-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04387058. Inclusion in this directory is not an endorsement.